Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological TumorsHaiting Duan, Jinxin Che, Jia Li et al.|Journal of Medicinal Chemistry|2024Cited by 19
Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemiaJingyu Zhang, Jinxin Che, Haiting Duan et al.|European Journal of Medicinal Chemistry|2023Cited by 14
Genetic introgression from commercial European pigs to the indigenous Chinese Lijiang breed and associated changes in phenotypesRuifei Yang, Xinxing Dong, Suyun Fang et al.|Genetics Selection Evolution|2024Cited by 8
Discovery of a New and Selective HPK1 PROTAC for Enhancing Tumor Immunotherapy through Eliminating GLK DegradationMingfei Wu, Xiaowu Dong, Xinfei Mao et al.|Journal of Medicinal Chemistry|2025Cited by 6